Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

C4B Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch C4B in IF und IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN6936545

Kurzübersicht für C4B Antikörper (ABIN6936545)

Target

Alle C4B (C4b) Antikörper anzeigen
C4B (C4b) (Complement Component C4b (C4b))

Reaktivität

  • 54
  • 23
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 63
  • 9
  • 3
Maus

Klonalität

  • 66
  • 9
Monoklonal

Konjugat

  • 32
  • 9
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser C4B Antikörper ist unkonjugiert

Applikation

  • 42
  • 30
  • 20
  • 18
  • 13
  • 13
  • 12
  • 7
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

SPM545
  • Spezifität

    This MAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human Complement 4d protein

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Known_Application: Immunofluorescence (1:50-1:100), Immunohistochemistry (Formalin-fixed) (1:200-1:400 for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 1 mM EDTA, pH 7.5-8.5, for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: Rejected Renal Transplant Tissue.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    C4B (C4b) (Complement Component C4b (C4b))

    Andere Bezeichnung

    C4B

    Hintergrund

    Acidic Complement C4, Basic C4, C4, C4-1, C4a Anaphylatoxin, C4A, C4A2, C4A3, C4A4, C4A6, C4b, C4B1, C4B12, C4d fragment, C4F, C4S, Complement C4 Gamma Chain, Complement Component 4A, Complement Component 4B,Complement 4d (C4d) (Acute Humoral Rejection Marker)
    Cellular localisation: Intracytoplasmic vacuoles of endothelial cells and Secreted

    Molekulargewicht

    192kDa (predicted)

    Gen-ID

    720, 721, 534847

    Pathways

    Komplementsystem
Sie sind hier:
Chat with us!